CN114605559A - Recombinant organophosphorus hydrolase and construction method and application thereof - Google Patents
Recombinant organophosphorus hydrolase and construction method and application thereof Download PDFInfo
- Publication number
- CN114605559A CN114605559A CN202210319448.4A CN202210319448A CN114605559A CN 114605559 A CN114605559 A CN 114605559A CN 202210319448 A CN202210319448 A CN 202210319448A CN 114605559 A CN114605559 A CN 114605559A
- Authority
- CN
- China
- Prior art keywords
- gly
- oph
- recombinant
- ala
- linker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000006996 Aryldialkylphosphatase Human genes 0.000 title claims abstract description 67
- 108010008184 Aryldialkylphosphatase Proteins 0.000 title claims abstract description 67
- 238000010276 construction Methods 0.000 title claims abstract description 10
- 108010075254 C-Peptide Proteins 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 239000013613 expression plasmid Substances 0.000 claims description 7
- 239000000575 pesticide Substances 0.000 claims description 7
- 238000003259 recombinant expression Methods 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 230000000593 degrading effect Effects 0.000 claims description 3
- 230000003252 repetitive effect Effects 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 102000004157 Hydrolases Human genes 0.000 claims 1
- 108090000604 Hydrolases Proteins 0.000 claims 1
- 230000003278 mimic effect Effects 0.000 claims 1
- 229940056692 resinol Drugs 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 abstract description 7
- 239000002131 composite material Substances 0.000 abstract description 2
- 230000009465 prokaryotic expression Effects 0.000 abstract description 2
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 70
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 45
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 37
- 102000004190 Enzymes Human genes 0.000 description 35
- 108090000790 Enzymes Proteins 0.000 description 35
- 230000000694 effects Effects 0.000 description 35
- 229940088598 enzyme Drugs 0.000 description 35
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 29
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 23
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 23
- 108010079364 N-glycylalanine Proteins 0.000 description 23
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 23
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 23
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 22
- XRTDOIOIBMAXCT-NKWVEPMBSA-N Gly-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)CN)C(=O)O XRTDOIOIBMAXCT-NKWVEPMBSA-N 0.000 description 21
- 238000000746 purification Methods 0.000 description 17
- IIQIOFVDFOLCHP-UHFFFAOYSA-N Asn-Pro-Ser-Ser Chemical compound NC(=O)CC(N)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CO)C(O)=O IIQIOFVDFOLCHP-UHFFFAOYSA-N 0.000 description 15
- 108010077245 asparaginyl-proline Proteins 0.000 description 15
- 239000006228 supernatant Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 241000589565 Flavobacterium Species 0.000 description 8
- QXPRJQPCFXMCIY-NKWVEPMBSA-N Gly-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN QXPRJQPCFXMCIY-NKWVEPMBSA-N 0.000 description 8
- MKGIILKDUGDRRO-FXQIFTODSA-N Pro-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 MKGIILKDUGDRRO-FXQIFTODSA-N 0.000 description 8
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 150000002903 organophosphorus compounds Chemical class 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000005185 salting out Methods 0.000 description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000001042 affinity chromatography Methods 0.000 description 4
- 108010047495 alanylglycine Proteins 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000006166 lysate Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 239000005944 Chlorpyrifos Substances 0.000 description 3
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 101150027424 oph gene Proteins 0.000 description 3
- WYMSBXTXOHUIGT-UHFFFAOYSA-N paraoxon Chemical compound CCOP(=O)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 WYMSBXTXOHUIGT-UHFFFAOYSA-N 0.000 description 3
- 229960004623 paraoxon Drugs 0.000 description 3
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 2
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 2
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 2
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 2
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 2
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 2
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 2
- RIPMDCIXRYWXSH-KNXALSJPSA-N Ala-Trp-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@@H]3C(=O)O)N RIPMDCIXRYWXSH-KNXALSJPSA-N 0.000 description 2
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 2
- OGUPCHKBOKJFMA-SRVKXCTJSA-N Arg-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N OGUPCHKBOKJFMA-SRVKXCTJSA-N 0.000 description 2
- FRMQITGHXMUNDF-GMOBBJLQSA-N Arg-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N FRMQITGHXMUNDF-GMOBBJLQSA-N 0.000 description 2
- OQPAZKMGCWPERI-GUBZILKMSA-N Arg-Ser-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OQPAZKMGCWPERI-GUBZILKMSA-N 0.000 description 2
- FTMRPIVPSDVGCC-GUBZILKMSA-N Arg-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N FTMRPIVPSDVGCC-GUBZILKMSA-N 0.000 description 2
- VHQOCWWKXIOAQI-WDSKDSINSA-N Asp-Gln-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O VHQOCWWKXIOAQI-WDSKDSINSA-N 0.000 description 2
- YUELDQUPTAYEGM-XIRDDKMYSA-N Asp-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)O)N YUELDQUPTAYEGM-XIRDDKMYSA-N 0.000 description 2
- 239000008000 CHES buffer Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- YJIUYQKQBBQYHZ-ACZMJKKPSA-N Gln-Ala-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YJIUYQKQBBQYHZ-ACZMJKKPSA-N 0.000 description 2
- PNENQZWRFMUZOM-DCAQKATOSA-N Gln-Glu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O PNENQZWRFMUZOM-DCAQKATOSA-N 0.000 description 2
- DRDSQGHKTLSNEA-GLLZPBPUSA-N Gln-Glu-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DRDSQGHKTLSNEA-GLLZPBPUSA-N 0.000 description 2
- FTIJVMLAGRAYMJ-MNXVOIDGSA-N Gln-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(N)=O FTIJVMLAGRAYMJ-MNXVOIDGSA-N 0.000 description 2
- FTTHLXOMDMLKKW-FHWLQOOXSA-N Gln-Phe-Phe Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 FTTHLXOMDMLKKW-FHWLQOOXSA-N 0.000 description 2
- NTBDVNJIWCKURJ-ACZMJKKPSA-N Glu-Asp-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NTBDVNJIWCKURJ-ACZMJKKPSA-N 0.000 description 2
- NJCALAAIGREHDR-WDCWCFNPSA-N Glu-Leu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NJCALAAIGREHDR-WDCWCFNPSA-N 0.000 description 2
- YTRBQAQSUDSIQE-FHWLQOOXSA-N Glu-Phe-Phe Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 YTRBQAQSUDSIQE-FHWLQOOXSA-N 0.000 description 2
- GVVKYKCOFMMTKZ-WHFBIAKZSA-N Gly-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)CN GVVKYKCOFMMTKZ-WHFBIAKZSA-N 0.000 description 2
- HFXJIZNEXNIZIJ-BQBZGAKWSA-N Gly-Glu-Gln Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFXJIZNEXNIZIJ-BQBZGAKWSA-N 0.000 description 2
- HKSNHPVETYYJBK-LAEOZQHASA-N Gly-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)CN HKSNHPVETYYJBK-LAEOZQHASA-N 0.000 description 2
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 2
- JPAACTMBBBGAAR-HOTGVXAUSA-N Gly-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)CN)CC(C)C)C(O)=O)=CNC2=C1 JPAACTMBBBGAAR-HOTGVXAUSA-N 0.000 description 2
- GGAPHLIUUTVYMX-QWRGUYRKSA-N Gly-Phe-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)C[NH3+])CC1=CC=CC=C1 GGAPHLIUUTVYMX-QWRGUYRKSA-N 0.000 description 2
- SSFWXSNOKDZNHY-QXEWZRGKSA-N Gly-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN SSFWXSNOKDZNHY-QXEWZRGKSA-N 0.000 description 2
- YOBGUCWZPXJHTN-BQBZGAKWSA-N Gly-Ser-Arg Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YOBGUCWZPXJHTN-BQBZGAKWSA-N 0.000 description 2
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 2
- VNNRLUNBJSWZPF-ZKWXMUAHSA-N Gly-Ser-Ile Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNNRLUNBJSWZPF-ZKWXMUAHSA-N 0.000 description 2
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 2
- XMENRVZYPBKBIL-AVGNSLFASA-N His-Glu-His Chemical compound N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O XMENRVZYPBKBIL-AVGNSLFASA-N 0.000 description 2
- KAXZXLSXFWSNNZ-XVYDVKMFSA-N His-Ser-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KAXZXLSXFWSNNZ-XVYDVKMFSA-N 0.000 description 2
- TZCGZYWNIDZZMR-UHFFFAOYSA-N Ile-Arg-Ala Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(C)C(O)=O)CCCN=C(N)N TZCGZYWNIDZZMR-UHFFFAOYSA-N 0.000 description 2
- PFTFEWHJSAXGED-ZKWXMUAHSA-N Ile-Cys-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)O)N PFTFEWHJSAXGED-ZKWXMUAHSA-N 0.000 description 2
- HTDRTKMNJRRYOJ-SIUGBPQLSA-N Ile-Gln-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HTDRTKMNJRRYOJ-SIUGBPQLSA-N 0.000 description 2
- NHJKZMDIMMTVCK-QXEWZRGKSA-N Ile-Gly-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N NHJKZMDIMMTVCK-QXEWZRGKSA-N 0.000 description 2
- KIAOPHMUNPPGEN-PEXQALLHSA-N Ile-Gly-His Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KIAOPHMUNPPGEN-PEXQALLHSA-N 0.000 description 2
- NYEYYMLUABXDMC-NHCYSSNCSA-N Ile-Gly-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)N NYEYYMLUABXDMC-NHCYSSNCSA-N 0.000 description 2
- CSQNHSGHAPRGPQ-YTFOTSKYSA-N Ile-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O)N CSQNHSGHAPRGPQ-YTFOTSKYSA-N 0.000 description 2
- SAVXZJYTTQQQDD-QEWYBTABSA-N Ile-Phe-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SAVXZJYTTQQQDD-QEWYBTABSA-N 0.000 description 2
- QHUREMVLLMNUAX-OSUNSFLBSA-N Ile-Thr-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)O)N QHUREMVLLMNUAX-OSUNSFLBSA-N 0.000 description 2
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 2
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 2
- HASRFYOMVPJRPU-SRVKXCTJSA-N Leu-Arg-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HASRFYOMVPJRPU-SRVKXCTJSA-N 0.000 description 2
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 2
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 2
- SQUFDMCWMFOEBA-KKUMJFAQSA-N Leu-Ser-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SQUFDMCWMFOEBA-KKUMJFAQSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 2
- WDTLNWHPIPCMMP-AVGNSLFASA-N Met-Arg-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O WDTLNWHPIPCMMP-AVGNSLFASA-N 0.000 description 2
- SQUTUWHAAWJYES-GUBZILKMSA-N Met-Asp-Arg Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SQUTUWHAAWJYES-GUBZILKMSA-N 0.000 description 2
- FVKRQMQQFGBXHV-QXEWZRGKSA-N Met-Asp-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FVKRQMQQFGBXHV-QXEWZRGKSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- MQVFHOPCKNTHGT-MELADBBJSA-N Phe-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O MQVFHOPCKNTHGT-MELADBBJSA-N 0.000 description 2
- XMQSOOJRRVEHRO-ULQDDVLXSA-N Phe-Leu-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 XMQSOOJRRVEHRO-ULQDDVLXSA-N 0.000 description 2
- FKYKZHOKDOPHSA-DCAQKATOSA-N Pro-Leu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FKYKZHOKDOPHSA-DCAQKATOSA-N 0.000 description 2
- 108010079005 RDV peptide Proteins 0.000 description 2
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 2
- MESDJCNHLZBMEP-ZLUOBGJFSA-N Ser-Asp-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MESDJCNHLZBMEP-ZLUOBGJFSA-N 0.000 description 2
- RNMRYWZYFHHOEV-CIUDSAMLSA-N Ser-Gln-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RNMRYWZYFHHOEV-CIUDSAMLSA-N 0.000 description 2
- YRBGKVIWMNEVCZ-WDSKDSINSA-N Ser-Glu-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O YRBGKVIWMNEVCZ-WDSKDSINSA-N 0.000 description 2
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 2
- HAYADTTXNZFUDM-IHRRRGAJSA-N Ser-Tyr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O HAYADTTXNZFUDM-IHRRRGAJSA-N 0.000 description 2
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 2
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 2
- CTONFVDJYCAMQM-IUKAMOBKSA-N Thr-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)N CTONFVDJYCAMQM-IUKAMOBKSA-N 0.000 description 2
- YOSLMIPKOUAHKI-OLHMAJIHSA-N Thr-Asp-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O YOSLMIPKOUAHKI-OLHMAJIHSA-N 0.000 description 2
- NIEWSKWFURSECR-FOHZUACHSA-N Thr-Gly-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O NIEWSKWFURSECR-FOHZUACHSA-N 0.000 description 2
- IMULJHHGAUZZFE-MBLNEYKQSA-N Thr-Gly-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IMULJHHGAUZZFE-MBLNEYKQSA-N 0.000 description 2
- MPUMPERGHHJGRP-WEDXCCLWSA-N Thr-Gly-Lys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O MPUMPERGHHJGRP-WEDXCCLWSA-N 0.000 description 2
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 2
- XYFISNXATOERFZ-OSUNSFLBSA-N Thr-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XYFISNXATOERFZ-OSUNSFLBSA-N 0.000 description 2
- VRUFCJZQDACGLH-UVOCVTCTSA-N Thr-Leu-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VRUFCJZQDACGLH-UVOCVTCTSA-N 0.000 description 2
- WYLAVUAWOUVUCA-XVSYOHENSA-N Thr-Phe-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WYLAVUAWOUVUCA-XVSYOHENSA-N 0.000 description 2
- OLFOOYQTTQSSRK-UNQGMJICSA-N Thr-Pro-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OLFOOYQTTQSSRK-UNQGMJICSA-N 0.000 description 2
- VGNLMPBYWWNQFS-ZEILLAHLSA-N Thr-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O VGNLMPBYWWNQFS-ZEILLAHLSA-N 0.000 description 2
- XGFYGMKZKFRGAI-RCWTZXSCSA-N Thr-Val-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N XGFYGMKZKFRGAI-RCWTZXSCSA-N 0.000 description 2
- NKMFRGPKTIEXSK-ULQDDVLXSA-N Tyr-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NKMFRGPKTIEXSK-ULQDDVLXSA-N 0.000 description 2
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 2
- COYSIHFOCOMGCF-UHFFFAOYSA-N Val-Arg-Gly Natural products CC(C)C(N)C(=O)NC(C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-UHFFFAOYSA-N 0.000 description 2
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 2
- QSPOLEBZTMESFY-SRVKXCTJSA-N Val-Pro-Val Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O QSPOLEBZTMESFY-SRVKXCTJSA-N 0.000 description 2
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 2
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 2
- 108010091092 arginyl-glycyl-proline Proteins 0.000 description 2
- 108010062796 arginyllysine Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 2
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 2
- 108010000761 leucylarginine Proteins 0.000 description 2
- 108010064235 lysylglycine Proteins 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003987 organophosphate pesticide Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000000447 pesticide residue Substances 0.000 description 2
- 108010084525 phenylalanyl-phenylalanyl-glycine Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108010071207 serylmethionine Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 1
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 1
- UGZUVYDKAYNCII-ULQDDVLXSA-N Arg-Phe-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UGZUVYDKAYNCII-ULQDDVLXSA-N 0.000 description 1
- PLTGTJAZQRGMPP-FXQIFTODSA-N Asn-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O PLTGTJAZQRGMPP-FXQIFTODSA-N 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 1
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 1
- ABPRMMYHROQBLY-NKWVEPMBSA-N Gly-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)CN)C(=O)O ABPRMMYHROQBLY-NKWVEPMBSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- FLONGDPORFIVQW-XGEHTFHBSA-N Ser-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FLONGDPORFIVQW-XGEHTFHBSA-N 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- -1 phosphate thiol esters Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/02—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by biological methods, i.e. processes using enzymes or microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/08—Phosphoric triester hydrolases (3.1.8)
- C12Y301/08001—Aryldialkylphosphatase (3.1.8.1), i.e. paraoxonase
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/20—Organic substances
- A62D2101/26—Organic substances containing nitrogen or phosphorus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Business, Economics & Management (AREA)
- Emergency Management (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides a recombinant organophosphorus hydrolase and a construction method and application thereof, belonging to the technical field of biological engineering; in the invention, organophosphorus hydrolase OPH and RNP are connected through flexible rigid composite connecting peptide Linker to construct recombinant organophosphorus hydrolase which is marked as OPH-Linker-RNP; the recombinant organophosphorus hydrolase can be expressed in a prokaryotic expression system of escherichia coli, and can be self-purified with high efficiency and good stability.
Description
Technical Field
The invention belongs to the technical field of bioengineering, and particularly relates to a recombinant organophosphorus hydrolase and a construction method and application thereof.
Background
The organophosphorus compound is an artificially synthesized phosphorus-containing high-toxicity substance, comprises phosphate esters, phosphate thiol esters, phosphonic acid or aminophosphate esters, V and G type nerve agents and the like, and is widely applied to the agricultural, industrial and national defense fields of pesticides, flame retardants, plasticizers, chemical weapons and the like. Organophosphorus can irreversibly bind to acetylcholinesterase in insects and mammals, leading to nervous system disorders and death in humans. Due to the limited ability of nature to degrade such compounds, the large amount of organophosphorus compounds used gradually accumulates, causing serious food and environmental problems. Organophosphorus hydrolase (OPH) is an enzyme which uses an organophosphorus compound as a substrate, can efficiently hydrolyze P-O, P-S, P-F and P-CN in the organophosphorus compound, and the hydrolysis product is non-toxic. Therefore, the method for solving the problem of organic phosphorus compound pollution in the environment by using the OPH is an environment-friendly method. The OPH can safely and thoroughly remove the residual pesticide on agricultural products such as fresh vegetables, melons and fruits, is fundamentally different from the mode that chemical detergents on the market adopt chemical raw materials to remove the pesticide residues by a physical method, and also avoids the defects that the chemical detergents cannot completely remove the pesticide residues and can form secondary pollution.
The wide demand for OPH has made it an important research topic. Since the original OPH obtained from the natural world often does not have high activity or poor thermal stability, and in addition, separation and purification are difficult, the initial cost of production is increased, and the enzyme activity is also lost. So that practical use of the organophosphorus hydrolase is limited. The microorganism has multiple metabolic pathways and short growth period, so that the biodegradation mode has the advantages of high degradation efficiency, mild condition and low cost, and shows better application potential. The enzyme plays a main role in the process of degrading the organophosphorus pesticide by the microorganisms, OPH catalyzes the breakage of the vinegar, and the obtained low-toxicity product can be further metabolized into carbon dioxide and water by the microorganisms. The development of organophosphorus hydrolase with high temperature resistance and easy purification through enzymatic engineering has become one of the hot spots of research. Currently, immobilized metal ion affinity chromatography (IMAC) has become a common technique for separation, purification and immobilization of histidine-tag (His-tag) containing enzymes. The use of transition metal ions (Ni) in IMAC materials2+、Co2+、Cu2 +Etc.) and histidine residue in target protein to realize the separation of His-tag proteinAnd (4) purifying and immobilizing. However, the procedure is complicated, time consuming, inefficient, does not increase the thermostability of the enzyme and preparation of the IMAC chelating agent can affect metalloenzyme activity.
Disclosure of Invention
Aiming at some defects in the prior art, the invention provides a recombinant organophosphorus hydrolase and a construction method and application thereof. In the invention, organophosphorus hydrolase OPH and resin-mimetic protein (RNP) are connected through flexible-rigid composite connecting peptide Linker to construct recombinant organophosphorus hydrolase which is marked as OPH-Linker-RNP; the recombinant organophosphorus hydrolase can be expressed in an escherichia coli prokaryotic expression system, and can be self-purified efficiently and has good stability.
The invention firstly provides a recombinant organophosphorus hydrolase, which is marked as OPH-Linker-RNP, the amino acid sequence of the recombinant organophosphorus hydrolase is shown as SEQ ID NO. 1, and the corresponding nucleotide sequence is shown as SEQ ID NO. 2.
The invention also provides a construction method of the recombinant organophosphorus hydrolase, which comprises the following steps: the organophosphorus hydrolase of Flavobacterium (Flavobacterium) is connected with RNP through a Linker to obtain the recombinant organophosphorus hydrolase OPH-Linker-RNP.
Wherein, the amino acid sequence of the recombinant organophosphorus hydrolase is shown as SEQ ID NO. 3, and the corresponding nucleotide sequence is shown as SEQ ID NO. 4; the RNP (resin-mimetic protein, RNP) is an artificial polypeptide which is composed of 30 repetitive sequences of 12 peptides (PSSSYGAPGGGN) and simulates a resin protein, and the amino acid sequence of the artificial polypeptide is shown as SEQ ID NO. 5; the Linker is connecting peptide GGGGSGGGGSEAAAKEAAAKGGGGSGGGGS, and the nucleotide sequence of the Linker is shown in SEQ ID NO. 7.
The invention also provides a recombinant expression plasmid, which contains nucleotide for coding the recombinant organophosphorus hydrolase and is marked as pET22b (+) -OPH-Linker-RNP.
The invention also provides a recombinant bacterium, which comprises the recombinant expression plasmid.
The invention also provides a method for purifying the recombinant organophosphorus hydrolase, and the purification method is a salting-out heating method.
The invention also provides application of the recombinant organophosphorus hydrolase, the recombinant expression plasmid or the recombinant bacterium in degrading organophosphorus pesticides.
Compared with the prior art, the invention has the beneficial effects that:
in the invention, the OPH is connected with the RNP, so that the OPH has thermal stability, the protein can be purified by salting out and heating, and the complicated experimental process of affinity chromatography is avoided. The OPH can be purified by the characteristics, and the purification times and the recovery rates of the OPH can respectively reach 9.39 and 9.51 times and 81.12 percent and 79.23 percent at 70-80 ℃. In addition, the method can increase the stability of the OPH enzyme, and the OPH-Linker enzyme activity is only 28.81 percent at 60 ℃, but the OPH-Linker-RNP can still maintain 80.43 percent of activity; at 80 ℃, the OPH-Linker enzyme activity is only 8.81 percent, and the OPH-Linker-RNP can still maintain 59.56 percent of activity.
The OPH-Linker-RNP recombinant organophosphorus hydrolase is constructed by a gene modification technology, compared with the organophosphorus hydrolase, the recombinant organophosphorus hydrolase has thermal stability, the target protein can be obtained only by simple processes such as salting out, heating, centrifuging and the like, and the method is simple and rapid and is superior to the traditional nickel column affinity chromatography purification mode in efficiency.
The recombinant OPH-Linker-RNP constructed by the invention can effectively work at a higher temperature (80 ℃) and is beneficial to improving the efficiency of an enzyme catalysis process. The fusion protein obtained by the invention is more suitable for the application of a biological catalysis process, can better meet the requirements of social production, and has wide market prospect.
Drawings
FIG. 1 is a schematic diagram of the construction of recombinant plasmid pET22b (+) OPH-Linker-RNP.
FIG. 2 is a SDS-PAGE graph of OPH-Linker-RNP induced expression and purification at 25 ℃; in the figure, M: standard protein molecular weight marker; 1: the crushed supernatant is induced and expressed by the empty vector; 2: OPH-Linker-RNP induces 0h to express the whole strain; 3: OPH-Linker-RNP enzyme induces for 8h to express the whole strain; 4: a precipitate containing OPH-Linker-RNP; 5: a supernatant solution containing OPH-Linker-RNP; 6: empty vector inductionExpressing the disrupted whole bacteria; 7-10: (NH)4)2SO4Heating the purified supernatant at 50, 60, 70, 80 ℃.
FIG. 3 is a graph showing the OPH-Linker-RNP recovery rate and purification fold after heating at different temperatures.
FIG. 4 is a graph showing the thermal stability of OPH-Linker-RNP and OPH-Linker in example 4.
FIG. 5 is a graph showing the storage stability of OPH-Linker-RNP and OPH-Linker of example 4.
Detailed Description
The invention will be further described with reference to the following figures and specific examples, but the scope of the invention is not limited thereto.
The following examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially. The invention adopts the prior art in the field except for special notes.
Example 1: construction of recombinant expression plasmids
An OPH gene (GenBank accession number CM29593.1) from Flavobacterium (Flavobacterium) is taken as a template, and the OPH nucleotide sequence is synthesized by the Kyoto bioengineering (Shanghai) corporation, wherein the OPH gene nucleotide sequence is shown as SEQ ID NO. 4, and the coded amino acid sequence is shown as SEQ ID NO. 3. The 5 'end and the 3' end of the OPH gene sequence are respectively modified with EcoR I and Hind III to obtain OPH nucleotide sequences with EcoR I and Hind III cutting sites, and the OPH nucleotide sequences with the EcoR I and Hind III cutting sites which are synthesized by the whole gene are constructed on pET22b (+) (Novagen company, USA) plasmid and named as pET22b (+) -OPH.
The Linker-RNP nucleotide sequence is synthesized by the whole gene of the company Limited in the biological engineering (Shanghai), the amino acid sequence of RNP is shown as SEQ ID NO. 5, and the nucleotide sequence is shown as SEQ ID NO. 6. The Linker nucleotide sequence is shown in SEQ ID NO. 7. A Hind III site is present 5 'to the linker and an Xho I site is present 3' to the RNP. The Linker-RNP nucleotide sequence synthesized above was then constructed on PUC18 plasmid (Stratagene, La Jolla, Calif., USA), and the resulting recombinant plasmid was designated PUC18-Linker-RNP plasmid.
SEQ ID NO:3:
MQTRRVVLKSAAAAGTLLGGLAGCASVAGSIGTGDRINTVRGPITISEAGFTLTHEHICGSSAGFLRAWPEFFGSRKALAEKAVRGLRRARAAGVRTIVDVSTFDIGRDVSLLAEVSRAADVHIVAATGLWFDPPLSMRLRSVEELTQFFLREIQYGIEDTGIRAGIIKVATTGKATPFQELVLKAAARASLATGVPVTTHTAASQRDGEQQAAIFESEGLSPSRVCIGHSDDTDDLSYLTALAARGYLIGLDHIPHSAIGLEDNASASALLGIRSWQTRALLIKALIDQGYMKQILVSNDWLFGFSSYVTNIMDVMDRVNPDGMAFIPLRVIPFLREKGVPQETLAGITVTNPARFLSPTLRAS
SEQ ID NO:4:
ATGCAAACGAGAAGGGTTGTGCTCAAGTCTGCGGCCGCCGCAGGAACTCTGCTCGGCGGCCTGGCTGGGTGCGCGAGCGTGGCTGGATCGATCGGCACAGGCGATCGGATCAATACCGTGCGCGGTCCTATCACAATCTCTGAAGCGGGTTTCACACTGACTCACGAGCACATCTGCGGCAGCTCGGCAGGATTCTTGCGTGCTTGGCCAGAGTTCTTCGGTAGCCGCAAAGCTCTAGCGGAAAAGGCTGTGAGAGGATTGCGCCGCGCCAGAGCGGCTGGCGTGCGAACGATTGTCGATGTGTCGACTTTCGATATCGGTCGCGACGTCAGTTTATTGGCCGAGGTTTCGCGGGCTGCCGACGTTCATATCGTGGCGGCGACCGGCTTGTGGTTCGACCCGCCACTTTCGATGCGATTGAGGAGTGTAGAGGAACTCACACAGTTCTTCCTGCGTGAGATTCAATATGGCATCGAAGACACCGGAATTAGGGCGGGCATTATCAAGGTCGCGACCACAGGCAAGGCGACCCCCTTTCAGGAGTTAGTGTTAAAGGCGGCCGCCCGGGCCAGCTTGGCCACCGGTGTTCCGGTAACCACTCACACGGCAGCAAGTCAGCGCGATGGTGAGCAGCAGGCCGCCATTTTTGAGTCCGAAGGCTTGAGCCCCTCACGGGTTTGTATTGGTCACAGCGATGATACTGACGATTTGAGCTATCTCACCGCCCTCGCTGCGCGCGGATACCTCATCGGTCTAGACCACATCCCGCACAGTGCGATTGGTCTAGAAGATAATGCGAGTGCATCAGCCCTCCTGGGCATCCGTTCGTGGCAAACACGGGCTCTCTTGATCAAGGCGCTCATCGACCAAGGCTACATGAAACAAATCCTCGTTTCGAATGACTGGCTGTTCGGGTTTTCGAGCTATGTCACCAACATCATGGACGTGATGGATCGCGTGAACCCCGACGGGATGGCCTTCATTCCACTGAGAGTGATCCCATTCCTACGAGAGAAGGGCGTCCCACAGGAAACGCTGGCAGGCATCACTGTGACTAACCCGGCGCGGTTCTTGTCACCGACCTTGCGGGCGTCA
SEQ ID NO:5:
PSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGG NPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGN
SEQ ID NO:6:
CCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAAC
SEQ ID NO:7:
GGCGGAGGTGGGAGCGGAGGTGGCGGGAGCGAAGCGGCAGCTAAGGAGGCGGCTGCCAAAGGCGGAGGTGGGAGCGGAGGTGGCGGGAGC
HindIII and Xho I were used to double cleave pET22b (+) -OPH and PUC18-Linker-RNP in the following systems:
Hind III:1μL;
Xho I:1μL;
10×Buffer:2μL;
PUC18-Linker-RNP or pET22b (+) -OPH: 5 mu L of the solution;
sterile water: make up to 20 μ L.
Adding the system into a centrifuge tube, mixing and uniformly mixing, and performing enzyme digestion at 37 ℃ for 2-3 h. Then, the Linker-RNP gene fragment and the linearized pET22b (+) -OPH are recovered according to a gel recovery kit (Takara Bio-engineering Co., Ltd.). The Linker-RNP gene fragment recovered from the gel was ligated with pET22b (+) -OPH by T4 ligase (Takara Shuzo Co., Ltd., Dalian). The connecting body is as follows:
10×T4 Ligase buffer:2μL;
pET22b (+) -OPH: depending on the concentration recovered;
PUC 18-Linker-RNP: depending on the concentration recovered;
T4 DNA Ligase(10U/μL):1μL;
sterile water: make up to 20 μ L.
The ligation reaction is carried out for 18h in an incubator at 16 ℃, after the reaction is finished, a recombinant plasmid pET22b (+) -OPH-Linker-RNP is obtained, named OPH-Linker-RNP, the amino acid sequence of the OPH-Linker-RNP is shown as SEQ ID NO:1, the nucleotide sequence for coding the OPH-Linker-RNP is shown as SEQ ID NO:2, and the nucleotide sequence and the restriction enzyme sites are shown as FIG. 1.
SEQ ID NO:1:
MQTRRVVLKSAAAAGTLLGGLAGCASVAGSIGTGDRINTVRGPITISEAGFTLTHEHICGSSAGFLRAWPEFFGSRKALAEKAVRGLRRARAAGVRTIVDVSTFDIGRDVSLLAEVSRAADVHIVAATGLWFDPPLSMRLRSVEELTQFFLREIQYGIEDTGIRAGIIKVATTGKATPFQELVLKAAARASLATGVPVTTHTAASQRDGEQQAAIFESEGLSPSRVCIGHSDDTDDLSYLTALAARGYLIGLDHIPHSAIGLEDNASASALLGIRSWQTRALLIKALIDQGYMKQILVSNDWLFGFSSYVTNIMDVMDRVNPDGMAFIPLRVIPFLREKGVPQETLAGITVTNPARFLSPTLRASGGGGSGGGGSEAAAKEAAAKGGGGSGGGGSPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGNPSSSYGAPGGGN
SEQ ID NO:2
ATGCAAACGAGAAGGGTTGTGCTCAAGTCTGCGGCCGCCGCAGGAACTCTGCTCGGCGGCCTGGCTGGGTGCGCGAGCGTGGCTGGATCGATCGGCACAGGCGATCGGATCAATACCGTGCGCGGTCCTATCACAATCTCTGAAGCGGGTTTCACACTGACTCACGAGCACATCTGCGGCAGCTCGGCAGGATTCTTGCGTGCTTGGCCAGAGTTCTTCGGTAGCCGCAAAGCTCTAGCGGAAAAGGCTGTGAGAGGATTGCGCCGCGCCAGAGCGGCTGGCGTGCGAACGATTGTCGATGTGTCGACTTTCGATATCGGTCGCGACGTCAGTTTATTGGCCGAGGTTTCGCGGGCTGCCGACGTTCATATCGTGGCGGCGACCGGCTTGTGGTTCGACCCGCCACTTTCGATGCGATTGAGGAGTGTAGAGGAACTCACACAGTTCTTCCTGCGTGAGATTCAATATGGCATCGAAGACACCGGAATTAGGGCGGGCATTATCAAGGTCGCGACCACAGGCAAGGCGACCCCCTTTCAGGAGTTAGTGTTAAAGGCGGCCGCCCGGGCCAGCTTGGCCACCGGTGTTCCGGTAACCACTCACACGGCAGCAAGTCAGCGCGATGGTGAGCAGCAGGCCGCCATTTTTGAGTCCGAAGGCTTGAGCCCCTCACGGGTTTGTATTGGTCACAGCGATGATACTGACGATTTGAGCTATCTCACCGCCCTCGCTGCGCGCGGATACCTCATCGGTCTAGACCACATCCCGCACAGTGCGATTGGTCTAGAAGATAATGCGAGTGCATCAGCCCTCCTGGGCATCCGTTCGTGGCAAACACGGGCTCTCTTGATCAAGGCGCTCATCGACCAAGGCTACATGAAACAAATCCTCGTTTCGAATGACTGGCTGTTCGGGTTTTCGAGCTATGTCACCAACATCATGGACGTGATGGATCGCGTGAACCCCGACGGGATGGCCTTCATTCCACTGAGAGTGATCCCATTCCTACGAGAGAAGGGCGTCCCACAGGAAACGCTGGCAGGCATCACTGTGACTAACCCGGCGCGGTTCTTGTCACCGACCTTGCGGGCGTCAGGCGGAGGTGGGAGCGGAGGTGGCGGGAGCGAAGCGGCAGCTAAGGAGGCGGCTGCCAAAGGCGGAGGTGGGAGCGGAGGTGGCGGGAGCCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAACCCGAGCAGCAGTTATGGCGCGCCGGGCGGTGGGAACCCAAGCAGTAGTTATGGCGCGCCGGGGGGCGGAAACCCTAGTAGCAGCTATGGCGCGCCGGGTGGAGGCAACCCCAGCAGCAGTTATGGCGCGCCGGGAGGTGGTAACCCCAGCAGTAGCTATGGCGCGCCGGGCGGTGGAAAC
Example 2: escherichia coli for expanding culture and expression of OPH-Linker-RNP
(1) The recombinant plasmid pET22b (+) -OPH-Linker-RNP obtained in example 1 was transformed into E.coli BL21(DE3) competence using a standard heat shock method to obtain transformed recombinant E.coli BL21(DE 3). Then the recombinant Escherichia coli BL21(DE3) was transferred to a solid LB medium (agar powder 15g/L, tryptone 10g/L, yeast extract 5g/L, sodium chloride 10g/L, pH7.4) supplemented with 50. mu.g/mL kanamycin, and cultured overnight at 37 ℃ and then the individual colonies after overnight culture were transferred to 5mL of a liquid LB medium (tryptone 10g/L, yeast extract 5g/L, sodium chloride 10g/L, pH7.4) containing 50. mu.g/mL kanamycin and cultured overnight at 37 ℃ with a orbital shaker at 200rpm, followed by 3mL of overnight-cultured Escherichia coli BL21 inoculated in 300mL of a liquid LB medium containing 50. mu.g/mL kanamycin at 37 ℃ for 3 hours at 200rpm until the OD of Escherichia coli BL21600To 0.4-0.6.
(2) The LB liquid medium containing recombinant E.coli BL21(DE3) obtained in step (1) was placed on ice for 20 minutes, to which isopropyl β -D-1-thiogalactopyranoside (IPTG) was added to a final concentration of 0.4mM, followed by shaking culture at 180rpm at 25 ℃ and 37 ℃ for 16-20 hours, respectively, to induce expression of recombinant organophosphorus hydrolase OPH-Linker-RNP. After induction expression, the liquid culture medium is centrifuged at 3000rpm and 4 ℃ for 20 minutes, the supernatant is discarded, cell precipitates cultured at different temperatures are obtained, and the cell precipitates are stored at-80 ℃ for later use.
(3) The cell pellets obtained in step (2) at the culture temperatures of 25 ℃ and 37 ℃ were thawed, resuspended in 10mL of Tris-HCl (50mM, pH 8.0), and centrifuged at 3000rpm for 20 minutes at 4 ℃ and the supernatant discarded, and the cells were collected and washed twice with 50mM Tris-HCl pH 8.0. Then, the cells were resuspended in 20mL of Tris-HCl buffer containing 1mM phenylmethylsulfonyl fluoride (PMSF, 200. mu.L) and subjected to ultrasonic lysis on ice for 30 minutes using an ultrasonic cell disruptor, followed by alternate sonication for 6s and intermittent cooling for 6s, and the whole reaction was allowed to proceed under an ice-water bath to obtain a lysate. After the completion of the sonication, the lysate was centrifuged at 14,000rpm for 30min at 4 ℃ to obtain the supernatant and the precipitate, the supernatant was transferred to a new EP tube, and the supernatant and the precipitate were stored.
In this example, in order to determine the form in which the expressed OPH-Linker-RNP exists, the above-obtained lysates, supernatants and pellets were subjected to SDS-PAGE analysis, and the results are shown in FIG. 2. FIG. 2 is a SDS-PAGE graph of OPH-Linker-RNP induced expression, and it can be seen from the graph that under the induction condition of 25 ℃, a band is obviously increased at the position of 75kDa of the target size in the supernatant of OPH-Linker-RNP, which indicates successful induction and obtains soluble recombinant OPH-Linker-RNP, so that the recombinant OPH-Linker-RNP exists in a soluble form.
Example 3: salting out and heating to purify OPH-Linker-RNP
In this example, OPH was purified by salting out heating, thereby confirming the purification performance and purification efficiency of OPH prepared in example 2. Adding appropriate amount of (NH) with concentration of 0.3-2.0M4)2SO4Adding into 500 μ L of clarified sample lysate, standing at 4 deg.C for 30min to allow protein to precipitate sufficiently, centrifuging at 15000g for 30min, and dissolving precipitate in PBS solution again. Heating the solution dissolved in PBS on a magnetic stirring heater at 50, 60, 70 and 80 ℃ for 15min respectively, naturally cooling at room temperature, centrifuging at 4 ℃ and 15000g for 15min, and collecting supernatant to obtain soluble protein solution, namely target protein OPH-Linker-RNP. And carrying out SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) electrophoresis detection and subsequent enzyme activity detection on the purified sample.
FIG. 3 is a SDS-PAGE graph of resuspended PBS buffer heated at different temperatures (50, 60, 70, 80 ℃) for 15min, from which it can be seen that the purification effect is best at 70-80 ℃. FIG. 4 shows the recovery rate and the purification multiple of OPH-Linker-RNP heated for 15min at different temperatures, and the results show that the purification multiple and the recovery rate at 70-80 ℃ can reach 9.39 times, 9.51 times, 81.12% and 79.23% respectively, and further show that the purification effect at 70-80 ℃ is optimal. Compared with the purification of recombinant protein containing His label through Ni-NTA affinity, the method of the invention has the advantages that the protein purification multiple is equivalent, but the target protein can be obtained only through the simple purification process of salting out and heating, the operation is simple, the purification time is short, and the tedious experimental process of affinity chromatography is avoided.
Example 4: heat stability and storage stability test of OPH-Linker-RNP
One of the products of the OPH for hydrolyzing the organophosphorus compound absorbs nitrophenol at the position of 400nm, so the enzyme activity of the organophosphorus hydrolase is calculated by detecting the concentration of the nitrophenol of the hydrolysate by an absorbance method. OPH-Linker was obtained by the method of example 3, except that RNP was not added, and the same procedure was used as a control.
1 OPH enzyme activity unit (U) is defined as the amount of enzyme required to hydrolyze 1. mu. mol/L of paraoxon per minute. OPH hydrolyzes a substrate (paraoxon) to generate a byproduct p-nitrophenol (PNP) having a maximum light absorption at 400nm, and thus OPH is performed by measuring a change in an absorbance value in a reaction system. The determination method comprises the following steps: the change of the absorbance value of the enzyme activity reaction system within 2min is measured at 400nm on an ultraviolet visible spectrophotometer (Beckman DU-800).
The enzyme activity reaction system is as follows: 445. mu.L of 250mM CHES buffer (1.244 g CHES dissolved in 40mL sterile deionized water, pH9.0 adjusted with 1M NaOH, and 100mL of methanol added), 440. mu.L of sterile deionized water, 5. mu.L of 10mM CoCl 210. mu.L of paraoxon at a concentration of 20mM and 100. mu.L of an organophosphorus hydrolase solution, totaling 1000. mu.L.
Equal amounts of OPH-Linker-RNP and OPH-Linker were kept at different temperatures (20-80 ℃) for 30 minutes without reaction solution (containing only OPH-Linker-RNP or OPH-Linker solution without reaction solution). The enzyme was then transferred to room temperature to adjust the enzyme temperature and centrifuged at 12000rpm for 10 minutes to remove denatured and precipitated proteins. The OPH enzyme activity is determined according to the method, the highest point enzyme activity is taken as 100%, other enzyme activity values are compared with the highest point enzyme activity value, and curves of different temperatures to relative activity are drawn.
FIG. 4 is a graph showing the thermal stability of OPH-Linker-RNP and OPH-Linker, from which it can be seen that the relative enzyme activities of OPH-Linker-RNP and OPH-Linker at different temperatures. When the temperature is increased to 50 ℃, the OPH-Linker enzyme activity is only 44.68%, and the OPH-Linker-RNP can still maintain 82.20% of activity; at 60 ℃, the activity of OPH-Linker enzyme is only 28.81 percent, and OPH-Linker-RNP can still keep 80.43 percent of activity; at 80 ℃, the OPH-Linker enzyme activity is only 8.81 percent, and the OPH-Linker-RNP can still maintain 59.56 percent of activity. Therefore, the OPH-Linker-RNP prepared by the invention has good thermal stability.
The storage stability of OPH-Linker-RNP and OPH-Linker was also examined in this example. And (2) storing the OPH-Linker-RNP and the OPH-Linker enzyme at 25 ℃, detecting the enzyme activity according to the method in the embodiment 4 when storing for 0, 6, 12, 24, 36, 42 and 48 days respectively, comparing other enzyme activities with the highest point enzyme activity by taking the highest point enzyme activity as 100%, and simultaneously drawing a curve of time to relative enzyme activity.
FIG. 5 is a graph showing the storage stability of OPH-Linker-RNP and OPH-Linker, i.e., the relative enzyme activities of OPH-Linker-RNP and OPH-Linker, when stored for different days. It can be seen from the figure that the OPH-Linker-RNP enzyme activity is high at 25 ℃ and the OPH-Linker enzyme activity is high.
In conclusion, the OPH-Linker-RNP enzyme has significantly higher thermal and storage stability than OPH-Linker enzyme. The heat and storage stability of the modified OPH is obviously improved, and the OPH can be quickly and efficiently separated and purified by self. The result shows that the strategy can be widely applied to the improvement of enzymology properties, accelerates the application of the enzyme in OPH production and life, and has important social and economic significance.
Example 5: degradation effect of OPH-Linker-RNP on organic pesticide
And (3) measuring the degradation efficiency of the OPH-Linker-RNP to 3 common organophosphorus pesticides (methyl parathion, methylamine and chlorpyrifos). The assay was performed by adding 10uL of a stock solution (final concentration: 2mM) of a pesticide substrate and 1U of purified OPH-Linker-RNP to 990uL of Tris-HcL buffer (50mM, pH 7.0) and reacting at 30 ℃ for 30 min. And (3) diluting and filtering the reaction solution, and then carrying out high performance liquid chromatography detection.
The HPLC analysis conditions of the methyl parathion are as follows: a C18 column; acetonitrile/water (70:30, v/v); 1.0 ml/min; 273 nm.
The methylamine HPLC analysis conditions are as follows: a C18 column; acetonitrile/water (70:30, v/v); 1.0 ml/min; 225 nm.
The chlorpyrifos HPLC analysis conditions are as follows: a C18 column; methanol/water (90:10, v/v); 1.0 ml/min; 230 nm.
The results show that the degradation rates of OPH-Linker-RNP on the tested methyl parathion, methylamine and chlorpyrifos are respectively 89.1%, 64.2% and 41.2%, which indicates that the OPH-Linker-RNP can degrade the tested organophosphorus pesticide.
The present invention is not limited to the above-described embodiments, and any obvious improvements, substitutions or modifications can be made by those skilled in the art without departing from the spirit of the present invention.
Sequence listing
<110> university of Jiangsu
<120> recombinant organophosphorus hydrolase, construction method and application thereof
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 755
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 1
Met Gln Thr Arg Arg Val Val Leu Lys Ser Ala Ala Ala Ala Gly Thr
1 5 10 15
Leu Leu Gly Gly Leu Ala Gly Cys Ala Ser Val Ala Gly Ser Ile Gly
20 25 30
Thr Gly Asp Arg Ile Asn Thr Val Arg Gly Pro Ile Thr Ile Ser Glu
35 40 45
Ala Gly Phe Thr Leu Thr His Glu His Ile Cys Gly Ser Ser Ala Gly
50 55 60
Phe Leu Arg Ala Trp Pro Glu Phe Phe Gly Ser Arg Lys Ala Leu Ala
65 70 75 80
Glu Lys Ala Val Arg Gly Leu Arg Arg Ala Arg Ala Ala Gly Val Arg
85 90 95
Thr Ile Val Asp Val Ser Thr Phe Asp Ile Gly Arg Asp Val Ser Leu
100 105 110
Leu Ala Glu Val Ser Arg Ala Ala Asp Val His Ile Val Ala Ala Thr
115 120 125
Gly Leu Trp Phe Asp Pro Pro Leu Ser Met Arg Leu Arg Ser Val Glu
130 135 140
Glu Leu Thr Gln Phe Phe Leu Arg Glu Ile Gln Tyr Gly Ile Glu Asp
145 150 155 160
Thr Gly Ile Arg Ala Gly Ile Ile Lys Val Ala Thr Thr Gly Lys Ala
165 170 175
Thr Pro Phe Gln Glu Leu Val Leu Lys Ala Ala Ala Arg Ala Ser Leu
180 185 190
Ala Thr Gly Val Pro Val Thr Thr His Thr Ala Ala Ser Gln Arg Asp
195 200 205
Gly Glu Gln Gln Ala Ala Ile Phe Glu Ser Glu Gly Leu Ser Pro Ser
210 215 220
Arg Val Cys Ile Gly His Ser Asp Asp Thr Asp Asp Leu Ser Tyr Leu
225 230 235 240
Thr Ala Leu Ala Ala Arg Gly Tyr Leu Ile Gly Leu Asp His Ile Pro
245 250 255
His Ser Ala Ile Gly Leu Glu Asp Asn Ala Ser Ala Ser Ala Leu Leu
260 265 270
Gly Ile Arg Ser Trp Gln Thr Arg Ala Leu Leu Ile Lys Ala Leu Ile
275 280 285
Asp Gln Gly Tyr Met Lys Gln Ile Leu Val Ser Asn Asp Trp Leu Phe
290 295 300
Gly Phe Ser Ser Tyr Val Thr Asn Ile Met Asp Val Met Asp Arg Val
305 310 315 320
Asn Pro Asp Gly Met Ala Phe Ile Pro Leu Arg Val Ile Pro Phe Leu
325 330 335
Arg Glu Lys Gly Val Pro Gln Glu Thr Leu Ala Gly Ile Thr Val Thr
340 345 350
Asn Pro Ala Arg Phe Leu Ser Pro Thr Leu Arg Ala Ser Gly Gly Gly
355 360 365
Gly Ser Gly Gly Gly Gly Ser Glu Ala Ala Ala Lys Glu Ala Ala Ala
370 375 380
Lys Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Pro Ser Ser Ser Tyr
385 390 395 400
Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly
405 410 415
Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro
420 425 430
Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr
435 440 445
Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly
450 455 460
Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro
465 470 475 480
Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr
485 490 495
Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly
500 505 510
Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro
515 520 525
Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr
530 535 540
Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly
545 550 555 560
Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro
565 570 575
Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr
580 585 590
Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly
595 600 605
Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro
610 615 620
Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr
625 630 635 640
Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly
645 650 655
Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro
660 665 670
Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr
675 680 685
Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly
690 695 700
Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro
705 710 715 720
Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr
725 730 735
Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly
740 745 750
Gly Gly Asn
755
<210> 2
<211> 2265
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 2
atgcaaacga gaagggttgt gctcaagtct gcggccgccg caggaactct gctcggcggc 60
ctggctgggt gcgcgagcgt ggctggatcg atcggcacag gcgatcggat caataccgtg 120
cgcggtccta tcacaatctc tgaagcgggt ttcacactga ctcacgagca catctgcggc 180
agctcggcag gattcttgcg tgcttggcca gagttcttcg gtagccgcaa agctctagcg 240
gaaaaggctg tgagaggatt gcgccgcgcc agagcggctg gcgtgcgaac gattgtcgat 300
gtgtcgactt tcgatatcgg tcgcgacgtc agtttattgg ccgaggtttc gcgggctgcc 360
gacgttcata tcgtggcggc gaccggcttg tggttcgacc cgccactttc gatgcgattg 420
aggagtgtag aggaactcac acagttcttc ctgcgtgaga ttcaatatgg catcgaagac 480
accggaatta gggcgggcat tatcaaggtc gcgaccacag gcaaggcgac cccctttcag 540
gagttagtgt taaaggcggc cgcccgggcc agcttggcca ccggtgttcc ggtaaccact 600
cacacggcag caagtcagcg cgatggtgag cagcaggccg ccatttttga gtccgaaggc 660
ttgagcccct cacgggtttg tattggtcac agcgatgata ctgacgattt gagctatctc 720
accgccctcg ctgcgcgcgg atacctcatc ggtctagacc acatcccgca cagtgcgatt 780
ggtctagaag ataatgcgag tgcatcagcc ctcctgggca tccgttcgtg gcaaacacgg 840
gctctcttga tcaaggcgct catcgaccaa ggctacatga aacaaatcct cgtttcgaat 900
gactggctgt tcgggttttc gagctatgtc accaacatca tggacgtgat ggatcgcgtg 960
aaccccgacg ggatggcctt cattccactg agagtgatcc cattcctacg agagaagggc 1020
gtcccacagg aaacgctggc aggcatcact gtgactaacc cggcgcggtt cttgtcaccg 1080
accttgcggg cgtcaggcgg aggtgggagc ggaggtggcg ggagcgaagc ggcagctaag 1140
gaggcggctg ccaaaggcgg aggtgggagc ggaggtggcg ggagcccgag cagcagttat 1200
ggcgcgccgg gcggtgggaa cccaagcagt agttatggcg cgccgggggg cggaaaccct 1260
agtagcagct atggcgcgcc gggtggaggc aaccccagca gcagttatgg cgcgccggga 1320
ggtggtaacc ccagcagtag ctatggcgcg ccgggcggtg gaaacccgag cagcagttat 1380
ggcgcgccgg gcggtgggaa cccaagcagt agttatggcg cgccgggggg cggaaaccct 1440
agtagcagct atggcgcgcc gggtggaggc aaccccagca gcagttatgg cgcgccggga 1500
ggtggtaacc ccagcagtag ctatggcgcg ccgggcggtg gaaacccgag cagcagttat 1560
ggcgcgccgg gcggtgggaa cccaagcagt agttatggcg cgccgggggg cggaaaccct 1620
agtagcagct atggcgcgcc gggtggaggc aaccccagca gcagttatgg cgcgccggga 1680
ggtggtaacc ccagcagtag ctatggcgcg ccgggcggtg gaaacccgag cagcagttat 1740
ggcgcgccgg gcggtgggaa cccaagcagt agttatggcg cgccgggggg cggaaaccct 1800
agtagcagct atggcgcgcc gggtggaggc aaccccagca gcagttatgg cgcgccggga 1860
ggtggtaacc ccagcagtag ctatggcgcg ccgggcggtg gaaacccgag cagcagttat 1920
ggcgcgccgg gcggtgggaa cccaagcagt agttatggcg cgccgggggg cggaaaccct 1980
agtagcagct atggcgcgcc gggtggaggc aaccccagca gcagttatgg cgcgccggga 2040
ggtggtaacc ccagcagtag ctatggcgcg ccgggcggtg gaaacccgag cagcagttat 2100
ggcgcgccgg gcggtgggaa cccaagcagt agttatggcg cgccgggggg cggaaaccct 2160
agtagcagct atggcgcgcc gggtggaggc aaccccagca gcagttatgg cgcgccggga 2220
ggtggtaacc ccagcagtag ctatggcgcg ccgggcggtg gaaac 2265
<210> 3
<211> 365
<212> PRT
<213> Flavobacterium (Flavobacterium)
<400> 3
Met Gln Thr Arg Arg Val Val Leu Lys Ser Ala Ala Ala Ala Gly Thr
1 5 10 15
Leu Leu Gly Gly Leu Ala Gly Cys Ala Ser Val Ala Gly Ser Ile Gly
20 25 30
Thr Gly Asp Arg Ile Asn Thr Val Arg Gly Pro Ile Thr Ile Ser Glu
35 40 45
Ala Gly Phe Thr Leu Thr His Glu His Ile Cys Gly Ser Ser Ala Gly
50 55 60
Phe Leu Arg Ala Trp Pro Glu Phe Phe Gly Ser Arg Lys Ala Leu Ala
65 70 75 80
Glu Lys Ala Val Arg Gly Leu Arg Arg Ala Arg Ala Ala Gly Val Arg
85 90 95
Thr Ile Val Asp Val Ser Thr Phe Asp Ile Gly Arg Asp Val Ser Leu
100 105 110
Leu Ala Glu Val Ser Arg Ala Ala Asp Val His Ile Val Ala Ala Thr
115 120 125
Gly Leu Trp Phe Asp Pro Pro Leu Ser Met Arg Leu Arg Ser Val Glu
130 135 140
Glu Leu Thr Gln Phe Phe Leu Arg Glu Ile Gln Tyr Gly Ile Glu Asp
145 150 155 160
Thr Gly Ile Arg Ala Gly Ile Ile Lys Val Ala Thr Thr Gly Lys Ala
165 170 175
Thr Pro Phe Gln Glu Leu Val Leu Lys Ala Ala Ala Arg Ala Ser Leu
180 185 190
Ala Thr Gly Val Pro Val Thr Thr His Thr Ala Ala Ser Gln Arg Asp
195 200 205
Gly Glu Gln Gln Ala Ala Ile Phe Glu Ser Glu Gly Leu Ser Pro Ser
210 215 220
Arg Val Cys Ile Gly His Ser Asp Asp Thr Asp Asp Leu Ser Tyr Leu
225 230 235 240
Thr Ala Leu Ala Ala Arg Gly Tyr Leu Ile Gly Leu Asp His Ile Pro
245 250 255
His Ser Ala Ile Gly Leu Glu Asp Asn Ala Ser Ala Ser Ala Leu Leu
260 265 270
Gly Ile Arg Ser Trp Gln Thr Arg Ala Leu Leu Ile Lys Ala Leu Ile
275 280 285
Asp Gln Gly Tyr Met Lys Gln Ile Leu Val Ser Asn Asp Trp Leu Phe
290 295 300
Gly Phe Ser Ser Tyr Val Thr Asn Ile Met Asp Val Met Asp Arg Val
305 310 315 320
Asn Pro Asp Gly Met Ala Phe Ile Pro Leu Arg Val Ile Pro Phe Leu
325 330 335
Arg Glu Lys Gly Val Pro Gln Glu Thr Leu Ala Gly Ile Thr Val Thr
340 345 350
Asn Pro Ala Arg Phe Leu Ser Pro Thr Leu Arg Ala Ser
355 360 365
<210> 4
<211> 1095
<212> DNA
<213> Flavobacterium (Flavobacterium)
<400> 4
atgcaaacga gaagggttgt gctcaagtct gcggccgccg caggaactct gctcggcggc 60
ctggctgggt gcgcgagcgt ggctggatcg atcggcacag gcgatcggat caataccgtg 120
cgcggtccta tcacaatctc tgaagcgggt ttcacactga ctcacgagca catctgcggc 180
agctcggcag gattcttgcg tgcttggcca gagttcttcg gtagccgcaa agctctagcg 240
gaaaaggctg tgagaggatt gcgccgcgcc agagcggctg gcgtgcgaac gattgtcgat 300
gtgtcgactt tcgatatcgg tcgcgacgtc agtttattgg ccgaggtttc gcgggctgcc 360
gacgttcata tcgtggcggc gaccggcttg tggttcgacc cgccactttc gatgcgattg 420
aggagtgtag aggaactcac acagttcttc ctgcgtgaga ttcaatatgg catcgaagac 480
accggaatta gggcgggcat tatcaaggtc gcgaccacag gcaaggcgac cccctttcag 540
gagttagtgt taaaggcggc cgcccgggcc agcttggcca ccggtgttcc ggtaaccact 600
cacacggcag caagtcagcg cgatggtgag cagcaggccg ccatttttga gtccgaaggc 660
ttgagcccct cacgggtttg tattggtcac agcgatgata ctgacgattt gagctatctc 720
accgccctcg ctgcgcgcgg atacctcatc ggtctagacc acatcccgca cagtgcgatt 780
ggtctagaag ataatgcgag tgcatcagcc ctcctgggca tccgttcgtg gcaaacacgg 840
gctctcttga tcaaggcgct catcgaccaa ggctacatga aacaaatcct cgtttcgaat 900
gactggctgt tcgggttttc gagctatgtc accaacatca tggacgtgat ggatcgcgtg 960
aaccccgacg ggatggcctt cattccactg agagtgatcc cattcctacg agagaagggc 1020
gtcccacagg aaacgctggc aggcatcact gtgactaacc cggcgcggtt cttgtcaccg 1080
accttgcggg cgtca 1095
<210> 5
<211> 360
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 5
Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser
1 5 10 15
Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro
20 25 30
Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn
35 40 45
Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser
50 55 60
Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro
65 70 75 80
Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn
85 90 95
Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser
100 105 110
Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro
115 120 125
Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn
130 135 140
Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser
145 150 155 160
Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro
165 170 175
Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn
180 185 190
Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser
195 200 205
Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro
210 215 220
Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn
225 230 235 240
Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser
245 250 255
Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro
260 265 270
Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn
275 280 285
Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser
290 295 300
Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro
305 310 315 320
Gly Gly Gly Asn Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn
325 330 335
Pro Ser Ser Ser Tyr Gly Ala Pro Gly Gly Gly Asn Pro Ser Ser Ser
340 345 350
Tyr Gly Ala Pro Gly Gly Gly Asn
355 360
<210> 6
<211> 1080
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
ccgagcagca gttatggcgc gccgggcggt gggaacccaa gcagtagtta tggcgcgccg 60
gggggcggaa accctagtag cagctatggc gcgccgggtg gaggcaaccc cagcagcagt 120
tatggcgcgc cgggaggtgg taaccccagc agtagctatg gcgcgccggg cggtggaaac 180
ccgagcagca gttatggcgc gccgggcggt gggaacccaa gcagtagtta tggcgcgccg 240
gggggcggaa accctagtag cagctatggc gcgccgggtg gaggcaaccc cagcagcagt 300
tatggcgcgc cgggaggtgg taaccccagc agtagctatg gcgcgccggg cggtggaaac 360
ccgagcagca gttatggcgc gccgggcggt gggaacccaa gcagtagtta tggcgcgccg 420
gggggcggaa accctagtag cagctatggc gcgccgggtg gaggcaaccc cagcagcagt 480
tatggcgcgc cgggaggtgg taaccccagc agtagctatg gcgcgccggg cggtggaaac 540
ccgagcagca gttatggcgc gccgggcggt gggaacccaa gcagtagtta tggcgcgccg 600
gggggcggaa accctagtag cagctatggc gcgccgggtg gaggcaaccc cagcagcagt 660
tatggcgcgc cgggaggtgg taaccccagc agtagctatg gcgcgccggg cggtggaaac 720
ccgagcagca gttatggcgc gccgggcggt gggaacccaa gcagtagtta tggcgcgccg 780
gggggcggaa accctagtag cagctatggc gcgccgggtg gaggcaaccc cagcagcagt 840
tatggcgcgc cgggaggtgg taaccccagc agtagctatg gcgcgccggg cggtggaaac 900
ccgagcagca gttatggcgc gccgggcggt gggaacccaa gcagtagtta tggcgcgccg 960
gggggcggaa accctagtag cagctatggc gcgccgggtg gaggcaaccc cagcagcagt 1020
tatggcgcgc cgggaggtgg taaccccagc agtagctatg gcgcgccggg cggtggaaac 1080
<210> 7
<211> 90
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
ggcggaggtg ggagcggagg tggcgggagc gaagcggcag ctaaggaggc ggctgccaaa 60
ggcggaggtg ggagcggagg tggcgggagc 90
Claims (8)
1. The recombinant organophosphorus hydrolase is characterized in that the recombinant organophosphorus hydrolase is marked as OPH-Linker-RNP, the amino acid sequence of the recombinant organophosphorus hydrolase is shown as SEQ ID NO. 1, and the nucleotide sequence for coding the recombinant organophosphorus hydrolase is shown as SEQ ID NO. 2.
2. The method for constructing a recombinant organophosphorus hydrolase according to claim 1, which comprises:
and (3) connecting the organophosphorus hydrolase OPH with the resinol mimic protein RNP through a connector to obtain the recombinant organophosphorus hydrolase OPH-connector-RNP.
3. The method for constructing recombinant organophosphorus hydrolase according to claim 2, wherein the amino acid sequence of organophosphorus hydrolase OPH is represented by SEQ ID NO. 3, and the nucleotide sequence encoding the organophosphorus hydrolase OPH is represented by SEQ ID NO. 4.
4. The method for constructing recombinant organophosphorus hydrolase according to claim 2, wherein said RNP is an artificial polypeptide which mimics a resin protein and is composed of 30 repetitive sequences of 12 peptides, and the amino acid sequence of said artificial polypeptide is represented by SEQ ID NO. 5.
5. The construction method of the recombinant organophosphorus hydrolase according to claim 2, wherein the Linker is connecting peptide GGGGSGGGGSEAAAKEAAAKGGGGSGGGGS, and the nucleotide sequence of the Linker is shown in SEQ ID NO. 7.
6. A recombinant expression plasmid comprising a nucleotide encoding the recombinant organophosphorous hydrolase according to claim 1.
7. A recombinant bacterium comprising the recombinant expression plasmid of claim 6.
8. The use of the recombinant organophosphorus hydrolase according to claim 1, the recombinant expression plasmid according to claim 6 or the recombinant bacterium according to claim 7 for degrading organophosphorus pesticides.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210319448.4A CN114605559B (en) | 2022-03-29 | 2022-03-29 | Recombinant organophosphorus hydrolase and construction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210319448.4A CN114605559B (en) | 2022-03-29 | 2022-03-29 | Recombinant organophosphorus hydrolase and construction method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114605559A true CN114605559A (en) | 2022-06-10 |
CN114605559B CN114605559B (en) | 2024-05-14 |
Family
ID=81866170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210319448.4A Active CN114605559B (en) | 2022-03-29 | 2022-03-29 | Recombinant organophosphorus hydrolase and construction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114605559B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190375804A1 (en) * | 2016-11-18 | 2019-12-12 | Pandorum Technologies Private Limited | Modular resilin-mimetic elastomeric platform |
CN110862974A (en) * | 2019-12-17 | 2020-03-06 | 克拉玛依市三达新技术股份有限公司 | Mutant of organophosphorus hydrolase, expression vector, recombinant bacterium and application |
CN111057702A (en) * | 2019-12-30 | 2020-04-24 | 北京电子科技职业学院 | Immobilized biological enzyme and application thereof in remediation of organophosphorus pesticide contaminated soil |
CN112029698A (en) * | 2020-09-14 | 2020-12-04 | 南开大学 | Engineering bacterium for degrading organophosphorus pesticide and construction method thereof |
CN113321742A (en) * | 2021-06-04 | 2021-08-31 | 江苏大学 | Recombinant superoxide dismutase and construction method and application thereof |
-
2022
- 2022-03-29 CN CN202210319448.4A patent/CN114605559B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190375804A1 (en) * | 2016-11-18 | 2019-12-12 | Pandorum Technologies Private Limited | Modular resilin-mimetic elastomeric platform |
CN110862974A (en) * | 2019-12-17 | 2020-03-06 | 克拉玛依市三达新技术股份有限公司 | Mutant of organophosphorus hydrolase, expression vector, recombinant bacterium and application |
CN111057702A (en) * | 2019-12-30 | 2020-04-24 | 北京电子科技职业学院 | Immobilized biological enzyme and application thereof in remediation of organophosphorus pesticide contaminated soil |
CN112029698A (en) * | 2020-09-14 | 2020-12-04 | 南开大学 | Engineering bacterium for degrading organophosphorus pesticide and construction method thereof |
CN113321742A (en) * | 2021-06-04 | 2021-08-31 | 江苏大学 | Recombinant superoxide dismutase and construction method and application thereof |
Non-Patent Citations (1)
Title |
---|
RAJKAMAL BALU,等: "Resilin-mimetica as a smart biomaterial platform for biomedical applications", NATURE COMMUNICATIONS, 8 January 2021 (2021-01-08), pages 1 - 15 * |
Also Published As
Publication number | Publication date |
---|---|
CN114605559B (en) | 2024-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108588052B (en) | Mutant of PET degrading enzyme and application thereof | |
CN113980141B (en) | Protein complex based on colicin E family DNase and application thereof in artificial protein scaffold | |
CN109971734B (en) | PH-insensitive high-temperature-tolerant HSL family lipid hydrolase and application thereof | |
Lai et al. | Cloning and sequencing of a cellobiose phosphotransferase system operon from Bacillus stearothermophilus XL-65-6 and functional expression in Escherichia coli | |
CN109055339B (en) | TEV protease mutant, gene, biological material, preparation method, reagent or kit and application | |
KR20150122542A (en) | Composition for CO2 capture comprising marine bacterium-derived recombinant biocatalyst, Method for preparing the same, and Method of CO2 capture using the same | |
CN101724611B (en) | Acid phytase APPA as well as mutant and preparation method thereof | |
CN114605559B (en) | Recombinant organophosphorus hydrolase and construction method and application thereof | |
WO2019056285A1 (en) | Heterologous expression of carbohydrate binding modules and uses thereof for cadaverine production | |
CN107446903B (en) | Salt-tolerant ethanol-tolerant pectinase with 3 optimal pH values and gene thereof | |
US6469145B1 (en) | One-step purification process for organophosphorus hydrolase enzyme | |
Suzuki et al. | Gene cloning, overproduction, and characterization of thermolabile alkaline phosphatase from a psychrotrophic bacterium | |
CN115058408B (en) | Metagenome-derived high-specific-activity acid-resistant D-psicose 3-epimerase and encoding gene and application thereof | |
CN113637663B (en) | Trypsin mutant with improved heat stability | |
CN111808874B (en) | Encoding gene of phosphotriesterase 8047-PTE and application thereof | |
CN112266905B (en) | Polypeptide modified amino acid dehydrogenase and preparation and immobilization method thereof | |
CN110358755B (en) | Acidic high-temperature-resistant recombinant cellulase and application thereof | |
CN109266634B (en) | Application of deinococcus radiodurans keratinase gene kerA | |
CN108841805B (en) | Lipase mutant with improved heat stability | |
CN111607573A (en) | Aminophosphine oxidoreductase with glyphosate degradation activity and application thereof | |
CN109234251B (en) | Protein and application of nucleic acid molecule for coding protein in preparation of phosphohydrolase | |
KR20140111240A (en) | Recombinant Vector and Recombinant Microorganism Comprising Chimeric kappa-Carrageenase Gene and Chimeric lamda-Carrageenase Gene | |
CN113528497B (en) | Use of FBA8 gene or FBA8 protein for preparing reagent with transphosphorylation activity and/or proteolytic activity | |
CN112143721B (en) | Low-temperature catalase and preparation method and application thereof | |
CN110862977B (en) | Sodium chloride and potassium chloride resistant xylosidase mutant H328D and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |